Annual ROE
-33.06%
-10.21%-44.68%
December 31, 2023
Summary
- As of February 8, 2025, ATOS annual return on equity is -33.06%, with the most recent change of -10.21% (-44.68%) on December 31, 2023.
- During the last 3 years, ATOS annual ROE has risen by +32.56% (+49.62%).
- ATOS annual ROE is now -125.91% below its all-time high of 127.59%, reached on December 31, 2010.
Performance
ATOS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-32.56%
-3.38%-11.58%
September 30, 2024
Summary
- As of February 8, 2025, ATOS quarterly return on equity is -32.56%, with the most recent change of -3.38% (-11.58%) on September 30, 2024.
- Over the past year, ATOS quarterly ROE has dropped by -5.09% (-18.53%).
- ATOS quarterly ROE is now -106.43% below its all-time high of 506.47%, reached on June 30, 2010.
Performance
ATOS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ATOS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.7% | -18.5% |
| 3 y3 years | +49.6% | -58.3% |
| 5 y5 years | +74.5% | -58.3% |
ATOS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -121.6% | at low | -122.6% | at low |
| 5 y | 5-year | -121.6% | +74.8% | -122.6% | +74.3% |
| alltime | all time | -125.9% | +96.6% | -106.4% | +92.5% |
Atossa Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -32.56%(+11.6%) |
| Jun 2024 | - | -29.18%(-6.7%) |
| Mar 2024 | - | -31.26%(+5.8%) |
| Dec 2023 | -33.06%(+44.7%) | -29.55%(+7.6%) |
| Sep 2023 | - | -27.47%(-0.1%) |
| Jun 2023 | - | -27.49%(+17.2%) |
| Mar 2023 | - | -23.45%(+10.3%) |
| Dec 2022 | -22.85%(+53.2%) | -21.26%(+15.4%) |
| Sep 2022 | - | -18.43%(+16.9%) |
| Jun 2022 | - | -15.77%(+0.8%) |
| Mar 2022 | - | -15.65%(+7.0%) |
| Dec 2021 | -14.92%(-77.3%) | -14.63%(-28.9%) |
| Sep 2021 | - | -20.57%(-23.4%) |
| Jun 2021 | - | -26.87%(-32.5%) |
| Mar 2021 | - | -39.80%(-68.6%) |
| Dec 2020 | -65.62%(-49.9%) | -126.64%(+3.3%) |
| Sep 2020 | - | -122.58%(+14.0%) |
| Jun 2020 | - | -107.56%(-5.5%) |
| Mar 2020 | - | -113.83%(+7.7%) |
| Dec 2019 | -131.04%(+1.2%) | -105.73%(-3.7%) |
| Sep 2019 | - | -109.74%(-7.4%) |
| Jun 2019 | - | -118.56%(+14.3%) |
| Mar 2019 | - | -103.77%(-13.1%) |
| Dec 2018 | -129.53%(+10.7%) | -119.42%(-4.2%) |
| Sep 2018 | - | -124.62%(-13.4%) |
| Jun 2018 | - | -143.95%(-23.8%) |
| Mar 2018 | - | -188.87%(-19.6%) |
| Dec 2017 | -117.06% | -234.87%(-32.2%) |
| Sep 2017 | - | -346.41%(+77.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | -195.09%(+5.7%) |
| Mar 2017 | - | -184.57%(+6.5%) |
| Dec 2016 | -205.64%(-13.6%) | -173.36%(-24.5%) |
| Sep 2016 | - | -229.65%(-18.2%) |
| Jun 2016 | - | -280.85%(+41.4%) |
| Mar 2016 | - | -198.69%(+15.2%) |
| Dec 2015 | -238.07%(+63.2%) | -172.40%(+18.7%) |
| Sep 2015 | - | -145.21%(+24.1%) |
| Jun 2015 | - | -117.02%(+12.0%) |
| Mar 2015 | - | -104.48%(+6.8%) |
| Dec 2014 | -145.85%(+6.7%) | -97.86%(+29.8%) |
| Sep 2014 | - | -75.41%(-11.0%) |
| Jun 2014 | - | -84.73%(-11.6%) |
| Mar 2014 | - | -95.87%(-24.3%) |
| Dec 2013 | -136.71%(-9.4%) | -126.66%(-7.9%) |
| Sep 2013 | - | -137.57%(-13.1%) |
| Jun 2013 | - | -158.39%(-17.1%) |
| Mar 2013 | - | -191.17%(-23.5%) |
| Dec 2012 | -150.84%(-84.5%) | -249.80%(-15.7%) |
| Sep 2012 | - | -296.27%(-31.9%) |
| Jun 2012 | - | -435.27%(+64.8%) |
| Mar 2012 | - | -264.16%(+63.7%) |
| Dec 2011 | -972.57%(-862.3%) | -161.40%(-41.6%) |
| Sep 2011 | - | -276.37%(-205.0%) |
| Jun 2011 | - | 263.16%(+0.6%) |
| Mar 2011 | - | 261.72%(+22.5%) |
| Dec 2010 | 127.59% | 213.58%(-8.3%) |
| Sep 2010 | - | 232.79%(-54.0%) |
| Jun 2010 | - | 506.47% |
FAQ
- What is Atossa Therapeutics annual return on equity?
- What is the all time high annual ROE for Atossa Therapeutics?
- What is Atossa Therapeutics annual ROE year-on-year change?
- What is Atossa Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Atossa Therapeutics?
- What is Atossa Therapeutics quarterly ROE year-on-year change?
What is Atossa Therapeutics annual return on equity?
The current annual ROE of ATOS is -33.06%
What is the all time high annual ROE for Atossa Therapeutics?
Atossa Therapeutics all-time high annual return on equity is 127.59%
What is Atossa Therapeutics annual ROE year-on-year change?
Over the past year, ATOS annual return on equity has changed by -10.21% (-44.68%)
What is Atossa Therapeutics quarterly return on equity?
The current quarterly ROE of ATOS is -32.56%
What is the all time high quarterly ROE for Atossa Therapeutics?
Atossa Therapeutics all-time high quarterly return on equity is 506.47%
What is Atossa Therapeutics quarterly ROE year-on-year change?
Over the past year, ATOS quarterly return on equity has changed by -5.09% (-18.53%)